WestEnd Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55K | Hold |
6
| – | – | ﹤0.01% | 172 |
|
|
2025
Q1 | $1.34K | Buy |
6
+4
| +200% | +$895 | ﹤0.01% | 185 |
|
|
2024
Q4 | $457 | Hold |
2
| – | – | ﹤0.01% | 185 |
|
|
2024
Q3 | $488 | Hold |
2
| – | – | ﹤0.01% | 175 |
|
|
2024
Q2 | $383 | Hold |
2
| – | – | ﹤0.01% | 186 |
|
|
2024
Q1 | $396 | Hold |
2
| – | – | ﹤0.01% | 172 |
|
|
2023
Q4 | $344 | Hold |
2
| – | – | ﹤0.01% | 187 |
|
|
2023
Q3 | $296 | Buy |
+2
| New | +$296 | ﹤0.01% | 198 |
|
|
2023
Q2 | – | Hold |
0
| – | -$438 | – | 249 |
|
|
2023
Q1 | – | Sell |
-2
| Closed | -$416 | – | 162 |
|
|
2022
Q4 | $416 | Hold |
2
| – | – | ﹤0.01% | 161 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 297 |
|
|
2022
Q2 | $419 | Buy |
+2
| New | +$419 | ﹤0.01% | 147 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$260 | – | 211 |
|
|
2021
Q4 | $260 | Buy |
+1
| New | +$260 | ﹤0.01% | 228 |
|
|
2021
Q3 | – | Hold |
0
| – | -$246K | – | 211 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 222 |
|